Market Cap N/A
Revenue (ttm) 80,000.00
Net Income (ttm) -4.91M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 200
Avg Vol 5,710
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 23%
Beta N/A
Analysts Strong Sell
Price Target N/A

Company Profile

Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs whi...

Phone: 833 275 2266
Address:
8181 Arista Place, Suite 100, Broomfield, United States
Latest News on ACONW
Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

Mar 19, 2026, 9:25 AM EDT - 19 hours ago

Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan


Aclarion to Present at the LD Micro Main Event XIX

Oct 9, 2025, 6:00 AM EDT - 5 months ago

Aclarion to Present at the LD Micro Main Event XIX


Aclarion Announces Texas Back Institute as New CLARITY Trial Site

May 12, 2025, 7:34 AM EDT - 11 months ago

Aclarion Announces Texas Back Institute as New CLARITY Trial Site


Aclarion Provides Shareholder Update

Mar 13, 2025, 9:25 AM EDT - 1 year ago

Aclarion Provides Shareholder Update


Aclarion Announces First Commercial Agreement in Michigan

Aug 14, 2024, 8:08 AM EDT - 1 year ago

Aclarion Announces First Commercial Agreement in Michigan


Aclarion Announces Closing of $3.0 Million Public Offering

Feb 27, 2024, 3:22 PM EST - 2 years ago

Aclarion Announces Closing of $3.0 Million Public Offering


Aclarion Announces Pricing of $3.0 Million Public Offering

Feb 26, 2024, 9:15 AM EST - 2 years ago

Aclarion Announces Pricing of $3.0 Million Public Offering